Bagshaw M A
Urol Clin North Am. 1984 May;11(2):297-304.
Resolution of pelvic lymph node metastases following irradiation can be demonstrated clinically by relief of obstructive symptoms and objectively by shrinkage of adenopathy as demonstrated by lymphography. Nevertheless, survival following nodal irradiation for patients with surgically proved pelvic or periaortic adenopathy or both at 10 years is only 20 per cent, whereas without adenopathy it is nearly 80 per cent. In spite of this relatively low level of survival, the firm documentation of survival without evidence of lymph node disease in 9 of 60 patients is ample justification for irradiation of regional lymphatics in these high-risk patients.
盆腔淋巴结转移灶经照射后的消退可通过梗阻症状的缓解在临床上得到证实，并且可通过淋巴管造影显示的腺病缩小在客观上得到证实。然而，经手术证实有盆腔或主动脉旁腺病或两者皆有的患者，接受淋巴结照射后的10年生存率仅为20%，而无腺病患者的生存率接近80%。尽管生存率相对较低，但60例患者中有9例在无淋巴结疾病证据的情况下生存的明确记录，足以证明对这些高危患者的区域淋巴管进行照射是合理的。
